Immunotherapy for advanced renal cell cancer - Test2 - elhamkhani - TriplyDB

Immunotherapy for advanced renal cell cancer

Immunotherapy for advanced renal cell cancer

http://www.wikidata.org/entity/Q24187300

about

Immunotherapy for Bone and Soft Tissue Sarcomas

P2860

Q28088363-09334700-96F5-48EB-B12D-0097F0D6C0B4

P2860

Immunotherapy for advanced renal cell cancer

http://www.wikidata.org/entity/Q24187300

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Immunotherapy for advanced renal cell cancer

@ast

Immunotherapy for advanced renal cell cancer

@en

Immunotherapy for advanced renal cell cancer

@nl

type

label

Immunotherapy for advanced renal cell cancer

@ast

Immunotherapy for advanced renal cell cancer

@en

Immunotherapy for advanced renal cell cancer

@nl

prefLabel

Immunotherapy for advanced renal cell cancer

@ast

Immunotherapy for advanced renal cell cancer

@en

Immunotherapy for advanced renal cell cancer

@nl

P1433

Q24187300-DB3D6C1A-3C9D-46C0-8B12-E41AEEBE7D09

P1476

Q24187300-2D7B738B-DF65-41AF-A602-8AB45557BF1E

P2093

Q24187300-2632C97D-14A4-41BB-A111-41F43A916FB9

Q24187300-C78B2FBE-EA6D-42A8-BC2D-61CA44ADDBF3

Q24187300-CC63D1BF-BC6B-44DF-8F67-C2CEE48DA62A

Q24187300-CCDD9CAE-F9FF-44C0-8525-B1C56E858003

Q24187300-D09F81AF-3FE9-4CCA-A310-8051064EC1DB

Q24187300-E7028980-ECFA-4138-B54D-798CA52C7F75

P2860

Q24187300-0449D7BC-18CD-4243-9E33-AA2D6788F6C6

Q24187300-04585758-7EBA-4C66-ADDA-1A7A46068465

Q24187300-0FA2EABA-2E98-4FFF-AFFE-C1AEBDB7F686

Q24187300-14A6AC2B-191C-4B60-B4E4-4608340C9A56

Q24187300-17967151-4235-42C5-BA3B-787A26125585

Q24187300-1A755002-186E-4ADD-8A07-A39CE6AEE91F

Q24187300-1BDB7FEA-8BA7-4C80-A6EB-07E41C610CE8

Q24187300-20D4C9DB-D1C1-4F42-B597-2521C2686548

Q24187300-267DB75D-6AB9-4E2D-8E25-F773AEC164F4

Q24187300-29CE97E3-9B8C-47B6-B646-C6D1F20675C9

P31

Q24187300-D4080372-B604-4839-8719-945B07BC7DD0

Q24187300-ebb1cbb6-f337-4c87-94aa-294fc604e57c

P3181

Q24187300-F8CC38D2-95DC-4DCC-8B7E-CAB2C42721C9

P356

Q24187300-455F3146-561E-4C96-B43A-F2BC94483259

P577

Q24187300-1CB4C6BF-EE16-4405-AF86-2DC2E8C906F2

P698

Q24187300-8A8FE7FD-C1CF-4321-994B-7CE6FCA6398A

P921

Q24187300-B1A39BA6-DBCB-4C75-86BD-2FADD8A09EBD

P3181

P356

14651858.CD001425.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Immunotherapy for advanced renal cell cancer

@en

P2093

Andrew Coldman

http://www.w3.org/2001/XMLSchema#string

Chris Coppin

http://www.w3.org/2001/XMLSchema#string

Franz Porzsolt

http://www.w3.org/2001/XMLSchema#string

Julia Kumpf

http://www.w3.org/2001/XMLSchema#string

Michael Autenrieth

http://www.w3.org/2001/XMLSchema#string

Timothy J Wilt

http://www.w3.org/2001/XMLSchema#string

P2860

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Reporting results of cancer treatment

Many reports of RCTs give insufficient data for Cochrane reviewers.

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.

Immunotherapy: the last 25 years.

P31

scholarly article

P3181

4679830

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001425.PUB3

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26713838

http://www.w3.org/2001/XMLSchema#string

P921